메뉴 건너뛰기




Volumn 132, Issue 9, 2013, Pages 2209-2216

Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer

Author keywords

colorectal cancer; methylation; microsatellite instability; oxaliplatin

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; FLUOROURACIL; FOLINIC ACID; NEUROGENIN 1; OXALIPLATIN; PROTEIN MLH1; SOMATOMEDIN B; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR RUNX3;

EID: 84874106654     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27888     Document Type: Article
Times cited : (53)

References (41)
  • 2
    • 73049112438 scopus 로고    scopus 로고
    • Worldwide variations in colorectal cancer
    • Center MM, Jemal A, Smith RA, et al. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009; 59: 366-78.
    • (2009) CA Cancer J Clin , vol.59 , pp. 366-378
    • Center, M.M.1    Jemal, A.2    Smith, R.A.3
  • 3
    • 77349083001 scopus 로고    scopus 로고
    • Nationwide Cancer Incidence in Korea, 2003-2005
    • Won Y, Sung J, Jung K, et al. Nationwide Cancer Incidence in Korea, 2003-2005. Cancer Res Treat 2009; 41: 122-31.
    • (2009) Cancer Res Treat , vol.41 , pp. 122-131
    • Won, Y.1    Sung, J.2    Jung, K.3
  • 4
    • 0025060806 scopus 로고
    • Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
    • Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990; 322: 352-8.
    • (1990) N Engl J Med , vol.322 , pp. 352-358
    • Moertel, C.G.1    Fleming, T.R.2    MacDonald, J.S.3
  • 5
    • 0031022988 scopus 로고    scopus 로고
    • Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer
    • O'Connell MJ, Mailliard JA, Kahn MJ, et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 1997; 15: 246-50.
    • (1997) J Clin Oncol , vol.15 , pp. 246-250
    • O'Connell, M.J.1    Mailliard, J.A.2    Kahn, M.J.3
  • 6
    • 2542615200 scopus 로고    scopus 로고
    • Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
    • Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 2343-51.
    • (2004) N Engl J Med , vol.350 , pp. 2343-2351
    • Andre, T.1    Boni, C.2    Mounedji-Boudiaf, L.3
  • 7
    • 67650315187 scopus 로고    scopus 로고
    • Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial
    • Andre T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009; 27: 3109-16.
    • (2009) J Clin Oncol , vol.27 , pp. 3109-3116
    • Andre, T.1    Boni, C.2    Navarro, M.3
  • 8
    • 79953217628 scopus 로고    scopus 로고
    • 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer
    • Jover R, Nguyen TP, Perez-Carbonell L, et al. 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer. Gastroenterology 2011; 140: 1174-81.
    • (2011) Gastroenterology , vol.140 , pp. 1174-1181
    • Jover, R.1    Nguyen, T.P.2    Perez-Carbonell, L.3
  • 9
    • 46349086833 scopus 로고    scopus 로고
    • Association between chromosomal instability and prognosis in colorectal cancer: A meta-analysis
    • Walther A, Houlston R, Tomlinson I,. Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 2008; 57: 941-50.
    • (2008) Gut , vol.57 , pp. 941-950
    • Walther, A.1    Houlston, R.2    Tomlinson, I.3
  • 10
    • 37149041833 scopus 로고    scopus 로고
    • Molecular classification and correlates in colorectal cancer
    • Ogino S, Goel A,. Molecular classification and correlates in colorectal cancer. J Mol Diagn 2008; 10: 13-27.
    • (2008) J Mol Diagn , vol.10 , pp. 13-27
    • Ogino, S.1    Goel, A.2
  • 11
    • 72449176846 scopus 로고    scopus 로고
    • Molecular origins of cancer: Molecular basis of colorectal cancer
    • Markowitz SD, Bertagnolli MM,. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 2009; 361: 2449-60.
    • (2009) N Engl J Med , vol.361 , pp. 2449-2460
    • Markowitz, S.D.1    Bertagnolli, M.M.2
  • 12
    • 77951627056 scopus 로고    scopus 로고
    • The chromosomal instability pathway in colon cancer
    • Pino MS, Chung DC,. The chromosomal instability pathway in colon cancer. Gastroenterology 2010; 138: 2059-72.
    • (2010) Gastroenterology , vol.138 , pp. 2059-2072
    • Pino, M.S.1    Chung, D.C.2
  • 13
    • 77449130761 scopus 로고    scopus 로고
    • Microsatellite instability in colorectal cancer
    • e3
    • Boland CR, Goel A,. Microsatellite instability in colorectal cancer. Gastroenterology 2010; 138: 2073-87 e3.
    • (2010) Gastroenterology , vol.138 , pp. 2073-2087
    • Boland, C.R.1    Goel, A.2
  • 14
    • 10744228074 scopus 로고    scopus 로고
    • Use of 5-fluorouracil and survival in patients with microsatellite- unstable colorectal cancer
    • Carethers JM, Smith EJ, Behling CA, et al. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology 2004; 126: 394-401.
    • (2004) Gastroenterology , vol.126 , pp. 394-401
    • Carethers, J.M.1    Smith, E.J.2    Behling, C.A.3
  • 15
    • 0038002279 scopus 로고    scopus 로고
    • Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
    • Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003; 349: 247-57.
    • (2003) N Engl J Med , vol.349 , pp. 247-257
    • Ribic, C.M.1    Sargent, D.J.2    Moore, M.J.3
  • 16
    • 33745541234 scopus 로고    scopus 로고
    • CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
    • Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38: 787-93.
    • (2006) Nat Genet , vol.38 , pp. 787-793
    • Weisenberger, D.J.1    Siegmund, K.D.2    Campan, M.3
  • 17
    • 73449118889 scopus 로고    scopus 로고
    • Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers
    • Kim JH, Shin SH, Kwon HJ, et al. Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers. Virchows Arch 2009; 455: 485-94.
    • (2009) Virchows Arch , vol.455 , pp. 485-494
    • Kim, J.H.1    Shin, S.H.2    Kwon, H.J.3
  • 18
    • 56649084987 scopus 로고    scopus 로고
    • Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample
    • Nosho K, Irahara N, Shima K, et al. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One 2008; 3: e3698.
    • (2008) PLoS One , vol.3
    • Nosho, K.1    Irahara, N.2    Shima, K.3
  • 19
    • 77949759545 scopus 로고    scopus 로고
    • The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status
    • Dahlin AM, Palmqvist R, Henriksson ML, et al. The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status. Clin Cancer Res 2010; 16: 1845-55.
    • (2010) Clin Cancer Res , vol.16 , pp. 1845-1855
    • Dahlin, A.M.1    Palmqvist, R.2    Henriksson, M.L.3
  • 20
    • 79955397102 scopus 로고    scopus 로고
    • DNA methylation predicts recurrence from resected stage III proximal colon cancer
    • Ahn JB, Chung WB, Maeda O, et al. DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer 2011; 117: 1847-54.
    • (2011) Cancer , vol.117 , pp. 1847-1854
    • Ahn, J.B.1    Chung, W.B.2    Maeda, O.3
  • 21
    • 58249089525 scopus 로고    scopus 로고
    • CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
    • Ogino S, Nosho K, Kirkner GJ, et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 2009; 58: 90-6.
    • (2009) Gut , vol.58 , pp. 90-96
    • Ogino, S.1    Nosho, K.2    Kirkner, G.J.3
  • 22
    • 0041524111 scopus 로고    scopus 로고
    • CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer
    • Van Rijnsoever M, Elsaleh H, Joseph D, et al. CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer. Clin Cancer Res 2003; 9: 2898-903.
    • (2003) Clin Cancer Res , vol.9 , pp. 2898-2903
    • Van Rijnsoever, M.1    Elsaleh, H.2    Joseph, D.3
  • 23
    • 79961137937 scopus 로고    scopus 로고
    • The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy
    • Min BH, Bae JM, Lee EJ, et al. The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy. BMC Cancer 2011; 11: 344.
    • (2011) BMC Cancer , vol.11 , pp. 344
    • Min, B.H.1    Bae, J.M.2    Lee, E.J.3
  • 24
    • 77951967408 scopus 로고    scopus 로고
    • Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin
    • Zaanan A, Cuilliere-Dartigues P, Guilloux A, et al. Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin. Ann Oncol 2010; 21: 772-80.
    • (2010) Ann Oncol , vol.21 , pp. 772-780
    • Zaanan, A.1    Cuilliere-Dartigues, P.2    Guilloux, A.3
  • 25
    • 78149327190 scopus 로고    scopus 로고
    • Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy
    • Kim ST, Lee J, Park SH, et al. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy. Cancer Chemother Pharmacol 2010; 66: 659-67.
    • (2010) Cancer Chemother Pharmacol , vol.66 , pp. 659-667
    • Kim, S.T.1    Lee, J.2    Park, S.H.3
  • 26
    • 33744550591 scopus 로고    scopus 로고
    • Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis
    • Ogino S, Kawasaki T, Brahmandam M, et al. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn 2006; 8: 209-17.
    • (2006) J Mol Diagn , vol.8 , pp. 209-217
    • Ogino, S.1    Kawasaki, T.2    Brahmandam, M.3
  • 27
    • 20244383592 scopus 로고    scopus 로고
    • Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer
    • Young J, Barker MA, Simms LA, et al. Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol 2005; 3: 254-63.
    • (2005) Clin Gastroenterol Hepatol , vol.3 , pp. 254-263
    • Young, J.1    Barker, M.A.2    Simms, L.A.3
  • 28
    • 34247570795 scopus 로고    scopus 로고
    • Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample
    • Ogino S, Kawasaki T, Kirkner GJ, et al. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn 2007; 9: 305-14.
    • (2007) J Mol Diagn , vol.9 , pp. 305-314
    • Ogino, S.1    Kawasaki, T.2    Kirkner, G.J.3
  • 29
    • 0035830503 scopus 로고    scopus 로고
    • Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms
    • Sun Y, Nadal-Vicens M, Misono S, et al. Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell 2001; 104: 365-76.
    • (2001) Cell , vol.104 , pp. 365-376
    • Sun, Y.1    Nadal-Vicens, M.2    Misono, S.3
  • 30
    • 33747587608 scopus 로고    scopus 로고
    • Regulation of the INK4b-ARF-INK4a tumour suppressor locus: All for one or one for all. Nature reviews
    • Gil J, Peters G,. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nature reviews. Mol Cell Biol 2006; 7: 667-77.
    • (2006) Mol Cell Biol , vol.7 , pp. 667-677
    • Gil, J.1    Peters, G.2
  • 31
    • 54249165951 scopus 로고    scopus 로고
    • Hypermethylator phenotype in sporadic colon cancer: Study on a population-based series of 582 cases
    • Barault L, Charon-Barra C, Jooste V, et al. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res 2008; 68: 8541-6.
    • (2008) Cancer Res , vol.68 , pp. 8541-8546
    • Barault, L.1    Charon-Barra, C.2    Jooste, V.3
  • 32
    • 78650733422 scopus 로고    scopus 로고
    • Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review
    • Shima K, Nosho K, Baba Y, et al. Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: cohort study and literature review. Int J Cancer 2011; 128: 1080-94.
    • (2011) Int J Cancer , vol.128 , pp. 1080-1094
    • Shima, K.1    Nosho, K.2    Baba, Y.3
  • 33
    • 77954954112 scopus 로고    scopus 로고
    • Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas
    • Kim JC, Choi JS, Roh SA, et al. Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas. Ann Surg Oncol 2010; 17: 1767-76.
    • (2010) Ann Surg Oncol , vol.17 , pp. 1767-1776
    • Kim, J.C.1    Choi, J.S.2    Roh, S.A.3
  • 34
    • 22244472992 scopus 로고    scopus 로고
    • Poor Survival Associated with the BRAF V600E Mutation in Microsatellite-Stable Colon Cancers
    • Samowitz WS, Sweeney C, Herrick J, et al. Poor Survival Associated with the BRAF V600E Mutation in Microsatellite-Stable Colon Cancers. Cancer Res 2005; 65: 6063-9.
    • (2005) Cancer Res , vol.65 , pp. 6063-6069
    • Samowitz, W.S.1    Sweeney, C.2    Herrick, J.3
  • 35
    • 79958806016 scopus 로고    scopus 로고
    • Four molecular subtypes of colorectal cancer and their precursor lesions
    • Kang GH,. Four molecular subtypes of colorectal cancer and their precursor lesions. Arch Pathol Lab Med 2011; 135: 698-703.
    • (2011) Arch Pathol Lab Med , vol.135 , pp. 698-703
    • Kang, G.H.1
  • 36
    • 77957197346 scopus 로고    scopus 로고
    • Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data
    • Guastadisegni C, Colafranceschi M, Ottini L, et al. Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. Eur J Cancer 2010; 46: 2788-98.
    • (2010) Eur J Cancer , vol.46 , pp. 2788-2798
    • Guastadisegni, C.1    Colafranceschi, M.2    Ottini, L.3
  • 37
    • 82555173112 scopus 로고    scopus 로고
    • Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy
    • Zaanan A, Fléjou J-Fo, Emile J-Fo, et al. Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy. Clin Cancer Res 2011; 17: 7470-8.
    • (2011) Clin Cancer Res , vol.17 , pp. 7470-7478
    • Zaanan, A.1    Fléjou, J.-F.2    Emile, J.-F.3
  • 38
    • 64649096900 scopus 로고    scopus 로고
    • Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and leukemia group B protocol 89803
    • Bertagnolli MM, Niedzwiecki D, Compton CC, et al. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: cancer and leukemia group B protocol 89803. J Clin Oncol 2009; 27: 1814-21.
    • (2009) J Clin Oncol , vol.27 , pp. 1814-1821
    • Bertagnolli, M.M.1    Niedzwiecki, D.2    Compton, C.C.3
  • 39
    • 38149135181 scopus 로고    scopus 로고
    • Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation
    • Lee S, Cho NY, Choi M, et al. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Pathol Int 2008; 58: 104-13.
    • (2008) Pathol Int , vol.58 , pp. 104-113
    • Lee, S.1    Cho, N.Y.2    Choi, M.3
  • 40
    • 54449092791 scopus 로고    scopus 로고
    • CpG island methylator phenotype in colorectal cancers: Comparison of the new and classic CpG island methylator phenotype marker panels
    • Lee S, Cho NY, Yoo EJ, et al. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels. Arch Pathol Lab Med 2008; 132: 1657-65.
    • (2008) Arch Pathol Lab Med , vol.132 , pp. 1657-1665
    • Lee, S.1    Cho, N.Y.2    Yoo, E.J.3
  • 41
    • 33644834827 scopus 로고    scopus 로고
    • Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: Individual patient data from 20,898 patients on 18 randomized trials
    • Sargent DJ, Wieand HS, Haller DG, et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2005; 23: 8664-70.
    • (2005) J Clin Oncol , vol.23 , pp. 8664-8670
    • Sargent, D.J.1    Wieand, H.S.2    Haller, D.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.